Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001344:Autopsy; D001659:Biliary Tract / Q000473:pathology; D001660:Biliary Tract Diseases / Q000473:pathology; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D002746:Chlorpromazine / Q000009:adverse effects; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007962:Leukocytes; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects*; D011346:Prochlorperazine / Q000009:adverse effects; D011395:Promazine / Q000009:adverse effects
D010640:Phenothiazines; D011395:Promazine; D002746:Chlorpromazine; D011346:Prochlorperazine